Subject(s)
Gout , Uric Acid , Humans , Gout/blood , Gout/diagnosis , Uric Acid/blood , Male , Female , Middle Aged , Adult , Symptom Flare Up , Risk Factors , Acute Disease , AgedABSTRACT
In the United States, approximately 2% to 3% of adults and 8% of children have a food allergy. Allergic reactions range from minor pruritus to life-threatening anaphylaxis. These allergies often lead to significant anxiety and costs for patients and caregivers. Common food allergies include peanuts, cow's milk, shellfish, tree nuts, egg, fish, soy, and wheat. Peanut allergy, the most common, is the leading cause of life-threatening anaphylaxis. Children with asthma, allergic rhinitis, atopic dermatitis, or an allergy to insect venom, medications, or latex are at an increased risk of developing food allergies. Diagnosis of food allergy starts with a detailed, allergy-focused history. Serum immunoglobulin E and skin prick testing provide reliable information regarding food allergy diagnoses. Primary treatment involves elimination of the offending food from the diet. Prevention strategies proven to decrease the risk of developing a food allergy include restricting exposure to cow's milk in the first three days of life and early sequential exposure to allergenic foods starting between four and six months of age. Exclusive breastfeeding for three to four months reduces the likelihood of developing eczema and asthma but does not reduce development of food allergies. Most children eventually outgrow allergies to cow's milk, egg, soy, and wheat. However, allergies to tree nuts, peanuts, and shellfish are more likely to be lifelong.
Subject(s)
Anaphylaxis , Asthma , Food Hypersensitivity , Peanut Hypersensitivity , Rhinitis, Allergic , Humans , Animals , Cattle , Female , Food Hypersensitivity/diagnosis , Food Hypersensitivity/prevention & control , Peanut Hypersensitivity/diagnosis , Peanut Hypersensitivity/prevention & control , ArachisSubject(s)
Escitalopram , Mindfulness , Humans , Adult , Anxiety Disorders/drug therapy , Anxiety/drug therapy , Stress, Psychological/therapySubject(s)
COVID-19 , Post-Acute COVID-19 Syndrome , Humans , COVID-19/epidemiology , COVID-19/prevention & control , VaccinationSubject(s)
Antidepressive Agents , Pharmacogenomic Testing , Humans , Genetic Testing , PharmacogeneticsABSTRACT
⺠Erectile dysfunction âºInsomnia ⺠Migraine headaches âºDisclosure of infidelity.
Subject(s)
Erectile Dysfunction , Migraine Disorders , Sleep Initiation and Maintenance Disorders , Disclosure , Erectile Dysfunction/drug therapy , Erectile Dysfunction/etiology , Humans , Male , Migraine Disorders/diagnosis , Sleep Initiation and Maintenance Disorders/diagnosis , Sleep Initiation and Maintenance Disorders/etiologySubject(s)
Aminobutyrates , Heart Failure , Aminobutyrates/therapeutic use , Angiotensin Receptor Antagonists/therapeutic use , Biphenyl Compounds , Double-Blind Method , Drug Combinations , Heart Failure/drug therapy , Humans , Stroke Volume , Tetrazoles/therapeutic use , Treatment Outcome , ValsartanSubject(s)
Amoxicillin , Community-Acquired Infections , Anti-Bacterial Agents , Child , Humans , Infant , Treatment OutcomeABSTRACT
BACKGROUND: Evidence-Based Medicine is built on the premise that clinicians can be more confident when their decisions are grounded in high-quality evidence. Furthermore, evidence from studies involving patient-oriented outcomes is preferred when making decisions about tests or treatments. Ideally, the findings of relevant and valid trials should be stable over time, that is, unlikely to be reversed in subsequent research. OBJECTIVE: To evaluate the stability of evidence from trials relevant to primary healthcare and to identify study characteristics associated with their reversal. METHODS: We studied synopses of randomized controlled trials (RCTs) published from 2002 to 2005 as "Daily POEMs" (Patient Oriented Evidence that Matters). The initial evidence (E1) from these POEMs (2002-2005) was compared with the updated evidence (E2) on that same topic in a summary resource (DynaMed 2019). Two physician-raters independently categorized each POEM-RCT as (i) reversed when E1 ≠ E2, or as (ii) not reversed, when E1 = E2. For all "Evidence Reversals" (E1 ≠ E2), we assessed the direction of change in the evidence. RESULTS: We evaluated 408 POEMs on RCTs. Of those, 35 (9%; 95% confidence interval [6-12]) were identified as reversed, 359 (88%) were identified as not reversed, and 14 (3%) were indeterminate. On average, this represents about 2 evidence reversals per annum for POEMs about RCTs. CONCLUSIONS: Over 12-17 years, 9% of RCTs summarized as POEMs are reversed. Information alerting services that apply strict criteria for relevance and validity of clinical information are likely to identify RCTs whose findings are stable over time.
We studied the extent to which evidence from randomized controlled trials (RCTs) relevant to primary care is contradicted in subsequent research. When it was, we identified this event as an evidence reversal. In addition, we sought to identify characteristics of RCTs associated with their reversal. From 408 RCTs published during the period 20022005, study characteristics such as sample size were identified and extracted. Subsequently, we compared the evidence reported in each of these RCTs with the evidence on that same topic in an online summary resource in 2019. This allowed us to classify each RCT in one of the following 3 categories: evidence confirmed, reversed, or uncertain if this evidence is confirmed or reversed. Over 1217 years of follow-up time, the findings of about 9 in 10 RCTs summarized as POEMs are stable. We found no statistically significant associations between trial characteristics and their subsequent reversal. This low rate of evidence reversal is good news for the RCTs that are used to inform decision-making.